The importance of 'state-of-the-art' cost-of-illness studies. Comment on: The economic burden of gout: A systemic review

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Article number	e9
Journal	Seminars in Arthritis and Rheumatism
Volume	45
Issue number	4
Early online date	17 Jun 2015
DOIs	https://doi.org/10.1016/j.semarthrit.2015.06.002
Publication status	Published - 1 Jan 2016

Access to Document

@article{9482944cd97f4cb18764e210f1e3d56c,

title = "The importance of 'state-of-the-art' cost-of-illness studies. Comment on: The economic burden of gout: A systemic review",

author = "Bartholomeus Spaetgens and A. Boonen",

year = "2016",

month = jan,

day = "1",

doi = "10.1016/j.semarthrit.2015.06.002",

language = "English",

volume = "45",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W B Saunders Co-Elsevier Inc",

number = "4",

}

TY - JOUR

T1 - The importance of 'state-of-the-art' cost-of-illness studies. Comment on: The economic burden of gout: A systemic review

AU - Spaetgens, Bartholomeus

AU - Boonen, A.

PY - 2016/1/1

Y1 - 2016/1/1

U2 - 10.1016/j.semarthrit.2015.06.002

DO - 10.1016/j.semarthrit.2015.06.002

M3 - Comment/Letter to the editor

SN - 0049-0172

VL - 45

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

IS - 4

M1 - e9

ER -